8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 18, 2007

Merck & Co., Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

New Jersey	1-3305	22-1109110
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey		08889
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 908-423-1000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the "Company") on December 17, 2007, attached as Exhibit 99.1, announcing the election of Harry R. Jacobson, M.D. to the Company's Board of Directors, effective December 18, 2007. Board Committee assignments for Dr. Jacobson will be determined at a later date.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press Release issued December 17, 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Merck & Co., Inc.
December 18, 2007	By:	/s/ Debra A. Bollwage
		Name: Debra A. Bollwage
		Title: Senior Assistant Secretary

Exhibit Index

Exhibit No.	Description
99.1	Press release issued December 17, 2007

EX-99.1

Exhibit 99.1

MERCK LOGO

News Release

Media Contact: Christopher Garland
(908) 423-3461 Investor Contact: Graeme Bell
(908) 423-5185

Harry Jacobson, M.D., Elected to Merck Board of Directors

WHITEHOUSE STATION, N.J., Dec. 17, 2007 – Merck & Co., Inc. today announced that Harry Jacobson, M.D., Vice Chancellor for Health Affairs at Vanderbilt University, will join the Company’s Board of Directors effective Dec. 18. Dr. Jacobson, 60, will be one of 12 outside directors on the 13-member Board. He will stand for election by the Company’s stockholders in April 2008.

Dr. Jacobson joined the faculty at the University of Texas Southwestern Medical School in Dallas in 1978 after completing two years of active duty in the U.S. Army as Chief of Nephrology at the U.S. Army Institute of Surgical Research at Brooke Army Medical Center. He joined the Vanderbilt Medical School faculty in 1985 as Professor of Medicine and Director of the Division of Nephrology and in 1997 became Vice Chancellor for Health Affairs. As part of his current role, Dr. Jacobson serves as Chief Executive Officer of Vanderbilt University Medical Center.

He is a member of the American Society for Clinical Investigation, the Association of American Physicians, and the Society of Medical Administrators. Dr. Jacobson is a member of the prestigious Institute of Medicine and also participates on the Board of Directors of the Nashville Health Care Council, the Middle Tennessee Council of the Boy Scouts of America, Ingram Industries and Kinetic Concepts Incorporated.

Dr. Jacobson earned his M.D. degree from the University of Illinois.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

# # #